TUFTS UNIVERSITY BOSTON
Evaluation of a polypeptide vaccine against Acinetobacter infection
Evaluation of a polypeptide vaccine against Acinetobacter infection is a funding opportunity from TUFTS UNIVERSITY BOSTON, up to 193591, closing March 31, 2027.
Mar 31, 2027
(243d left)Overview
Abstract Acinetobacter baumannii (Ab) is a Gram-negative bacterium emerging as a major cause of nosocomial infections. The most frequent clinical manifestations of Ab infection are ventilator-associated pneumonia and catheter-related bloodstream/urinary infection, in addition to that of wounds. The rapid emergence of…